A Phase III Multicenter Randomized, Double-blind, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Adult Patients With Relapsing Multiple Sclerosis
This study is testing an investigational medication called fenebrutinib to see how well it works and if it is safe for adults with relapsing multiple sclerosis. Researchers want to find out if it can help slow down physical disability and reduce the number of attacks compared to an existing treatment called teriflunomide.
You might be eligible if you are an adult with a confirmed diagnosis of relapsing multiple sclerosis and can still walk short distances and use your hands for simple tasks. People who are pregnant, breastfeeding, or have certain types of multiple sclerosis that do not have relapses cannot join.
Participants are randomly chosen to receive either the new study medication, fenebrutinib, or the approved medication, teriflunomide, along with dummy pills that look like the real medicine to keep the study fair. Your health and disability progress will be closely monitored throughout the study by the medical team.
This study has locations in places like Alabama, Arizona, and California, though it is currently active and not looking for new participants right now.
- 1Testing a new medication called fenebrutinib for relapsing multiple sclerosis
- 2Comparing the new drug against an approved treatment called teriflunomide
- 3The study is active but not currently accepting new participants
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.